<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04914312</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00014007</org_study_id>
    <nct_id>NCT04914312</nct_id>
  </id_info>
  <brief_title>Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction</brief_title>
  <official_title>Beneficial Effects of Maqui Berry Extract Combination With Omega-3 Fatty Acids on Cytokine Reduction in Elderly Obese Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to determine the effect of maqui extract plus omega-3 fatty&#xD;
      acids compared to a placebo for reducing inflammatory cytokine levels in older, obese adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anthocyanins, a subclass of flavonoids, are plant pigments that provide the rich color of&#xD;
      many plants, fruits, and flowers. Health benefits of anthocyanins have been widely reported&#xD;
      in the research literature, particularly for disease conditions associated with oxidative&#xD;
      stress, such as cardiovascular and neurodegenerative diseases. Emerging evidence suggests&#xD;
      that anthocyanins may also modulate gut microbiota, which can impact a wide variety of health&#xD;
      conditions. Maqui berries (Aristotelia chilensis), indigenous to Chile, have one of the&#xD;
      highest concentrations of anthocyanins in the plant world; moreover, the dominant anthocyanin&#xD;
      in maqui berries is delphinidin. Delphinidin is more bioavailable than most flavonoids, with&#xD;
      intact molecules absorbed in appreciable amounts in less than an hour after consumption.&#xD;
      Systemic effects of delphinidin include reduced inflammation due to downregulation of NF-kB,&#xD;
      the transcription factor that initiates the generation of pro-inflammatory cytokines. The&#xD;
      omega-3 fatty acid eicosapentaenoic acid [EPA], a component of omega-3 fatty acid&#xD;
      concentrates, also has anti-inflammatory properties. There is much empirical evidence&#xD;
      demonstrating beneficial effects of EPA supplementation, linked mainly to reductions in&#xD;
      inflammation. It has been demonstrated the dietary supplementation with EPA-rich marine oil&#xD;
      concentrations reduces cytokine levels up to 15%.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized, controlled trial</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Experimental capsules matched to placebo capsules</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Interleukin-6 (IL-6)</measure>
    <time_frame>change from baseline at day 56</time_frame>
    <description>Blood concentrations of IL-6</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interleukin-1 beta (IL-1 beta)</measure>
    <time_frame>change from baseline at day 56</time_frame>
    <description>Blood concentration of IL-1 beta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tumor Necrosis Factor (TNF)</measure>
    <time_frame>change from baseline at day 56</time_frame>
    <description>Blood concentration of TNF</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arachidonic acid (AA)</measure>
    <time_frame>change from baseline at day 56</time_frame>
    <description>Blood concentration of AA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eicosapentaenoic acid (EPA)</measure>
    <time_frame>change from baseline at day 56</time_frame>
    <description>Blood concentration of EPA</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Maqui berry extract and omega-3 fatty acids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 capsules BID per day containing a total of 600 mg of Maqui extract; 4 capsules per day supplying a total of 2000 mg EPA and 1000 mg DHA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>4 olive oil soft gelatin capsules and inert two-piece capsules containing maltodextrin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Maqui berry/omeg-3 fatty acids</intervention_name>
    <description>2 capsules BID per day containing a total of 600 mg of Maqui extract; 4 capsules per day supplying a total of 2000 mg EPA and 1000 mg DHA</description>
    <arm_group_label>Maqui berry extract and omega-3 fatty acids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>4 olive oil soft gelatin capsules and inert two-piece capsules containing maltodextrin</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females 50-85 years old&#xD;
&#xD;
          -  Generally healthy, non-smoker&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
          -  BMI: 30-40 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Existing auto-immune conditions&#xD;
&#xD;
          -  Use of warfarin or other blood thinners&#xD;
&#xD;
          -  Use of anti-inflammatory drugs, cardiovascular medications, lipid-altering drugs, and&#xD;
             hormone replacement therapy&#xD;
&#xD;
          -  Individuals engaged in vigorous exercise (&gt;2 x 30 min/week), vegetarians, and people&#xD;
             who routinely take multivitamins or herbal supplements.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 31, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Arizona State University</investigator_affiliation>
    <investigator_full_name>Carol Johnston</investigator_full_name>
    <investigator_title>Professor and Associate Dean</investigator_title>
  </responsible_party>
  <keyword>maqui berry extract</keyword>
  <keyword>omega-3 fatty acids</keyword>
  <keyword>cytokines</keyword>
  <keyword>blood lipids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

